Life sciences industry forecast for 2023 and beyond

Life sciences companies are facing several distinct challenges as we embark into another year filled with risk and uncertainty. From evolving regulations in the U.S. and abroad, to worsening economic conditions and the possible impact on what some people consider a “recession-proof” industry, to changing market dynamics that are affecting the use and importance of data and real-world evidence, there are many developments to be aware of.   

Listen to Baker Tilly’s informative, on-demand Life Sciences Industry Forecast event where our team of life science professionals explored developments from this past year, discussed the current state of the environment and looked at trends and challenges shaping the industry in 2023 and beyond. Topics of discussion included healthcare market dynamics, capital markets, the regulatory landscape, engagements with healthcare providers (HCPs), health equity, a snapshot of the global environment and more.